Vorinostat

Product description: Vorinostat (SAHA, MK0683, Zolinza) inhibits the enzymatic activity of histone deacetylases HDAC1, HDAC2 and HDAC3 (Class I) and HDAC6 (Class II) at nanomolar concentrations (IC50< 86 nM). These enzymes catalyze the removal of acetyl groups from the lysine residues of histones proteins. In some cancer cells, there is an overexpression of HDACs, or an aberrant recruitment of HDACs to oncogenic transcription factors causing hypoacetylation of core nucleosomal histones. By inhibiting histone deacetylase, vorinostat causes the accumulation of acetylated histones and induces cell cycle arrest and/or apoptosis of some transformed cells. The mechanism of the antineoplastic effect of vorinostat has not been fully characterized.

Alternate Names/Synonyms: SAHA; Suberoyl anilide bishydroxamide; Suberoylanilide hydroxamic acid;

Product Type: Chemical

Molecular Formula: C14H20N2O3

Molecular Weight: 264.3

CAS: 149647-78-9

Purity: >95%

InChiKey: WAEXFXRVDQXREF-UHFFFAOYSA-N

Appearance Solid.

Solubility: Soluble in DMSO or ethanol. Almost insoluble in water.

Short Term Storage: +4°C

Long Term Storage: -20°C

Shipping: AMBIENT

Use & Stability: Stable for at least 2 years after receipt when stored at -20°C.

Lien vers la Fiche Technique